Lynne E. Wagoner

4.6k total citations · 1 hit paper
52 papers, 3.3k citations indexed

About

Lynne E. Wagoner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lynne E. Wagoner has authored 52 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Lynne E. Wagoner's work include Heart Failure Treatment and Management (12 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Transplantation: Methods and Outcomes (7 papers). Lynne E. Wagoner is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Transplantation: Methods and Outcomes (7 papers). Lynne E. Wagoner collaborates with scholars based in United States and Canada. Lynne E. Wagoner's co-authors include Stephen B. Liggett, William T. Abraham, Albert M. Levin, Kersten M. Small, Sharon L. R. Kardia, Gerald W. Dorn, Thierry H. LeJemtel, Darlene P. Horton, Robert C. Bourge and Allen D. Johnson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Lynne E. Wagoner

52 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure

2000 669 citations Wilson S. Colucci, Uri Elkayam et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Lynne E. Wagoner

Since Specialization

Citations

This map shows the geographic impact of Lynne E. Wagoner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne E. Wagoner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne E. Wagoner more than expected).

Fields of papers citing papers by Lynne E. Wagoner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne E. Wagoner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne E. Wagoner. The network helps show where Lynne E. Wagoner may publish in the future.

Co-authorship network of co-authors of Lynne E. Wagoner

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne E. Wagoner. A scholar is included among the top collaborators of Lynne E. Wagoner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne E. Wagoner. Lynne E. Wagoner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Impact of the Addition of Ventilatory Efficiency to the Seattle Heart Failure Model in Patients With Heart Failure 2012 ·Journal of Cardiac Failure ·Wayne C. Levy, Ross Arena, Lynne E. Wagoner, Todd Dardas, William T. Abraham	11
2	Multiple interactions between the alpha2C- and beta1-adrenergic receptors influence heart failure survival 2008 ·BMC Medical Genetics ·Sharon L. R. Kardia, Reagan Kelly, Mehdi Keddache, Bruce J. Aronow, Gregory A. Grabowski, Harvey S. Hahn, (unknown), Lynne E. Wagoner, Gerald W. Dorn, Stephen B. Liggett	18
3	Abstract 2048: Angiogenesis Protein Therapy With Human Fibroblast Growth Factor (fgf-1): Results Of A Phase I Open Label, Dose Escalation Study In Subjects With CAD Not Eligible For PCI Or CABG 2007 ·Circulation ·Lynne E. Wagoner, Walter H. Merrill, (unknown), (unknown), John Boehmer, Kenneth A. Thomas, (unknown)	4
4	Cardiac Function and Heart Failure 2006 ·Journal of the American College of Cardiology ·Lynne E. Wagoner, Randall C. Starling, Christopher M. O’Connor	13
5	Highlights of the 55th Annual Scientific Session of the American College of Cardiology—March 11–14, 2006 2006 ·Journal of the American College of Cardiology ·Robert A. Harrington, Christopher M. O’Connor, James H. Stein, Matthew R. Wolff, Rhondalyn C. McLean, Emile R. Mohler, Roger S. Blumenthal, William D. Knopf, John A. Ambrose, Lynne E. Wagoner, Randall C. Starling, Raymond J. Kim, Steven M. Markowitz, Michael J. Landzberg, Ross M. Ungerleider, Shahbudin H. Rahimtoola, (unknown), JoAnne M. Foody	1
6	Emergency Department Observation of Heart Failure: Preliminary Analysis of Safety and Cost 2005 ·Congestive Heart Failure ·Alan B. Storrow, Sean P. Collins, Michael S. Lyons, Lynne E. Wagoner, W. Brian Gibler, Christopher J. Lindsell	51
7	Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes 2004 ·Journal of Allergy and Clinical Immunology ·(unknown), Sean C. Jameson, Blythe Thomson, Margaret H. Collins, Lynne E. Wagoner, (unknown), Lisa A. Beck, Joshua A. Boyce, Alexandra H. Filipovich, Joyce Villanueva, (unknown), (unknown), (unknown)	282
8	Recurrent primary cardiac malignant fibrous histiocytoma following orthotopic heart transplantation 2004 ·The Journal of Heart and Lung Transplantation ·Shahab A. Akhter, (unknown), (unknown), (unknown), Walter H. Merrill, Lynne E. Wagoner	4
9	Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature 2004 ·The Journal of Heart and Lung Transplantation ·Michael Schaeffer, Joseph F. Buell, Manish Gupta, (unknown), Shahab A. Akhter, Lynne E. Wagoner	61
10	Experience with 274 Cardiac Transplant Recipients with Posttransplant Lymphoproliferative Disorder: A Report from the Israel Penn International Transplant Tumor Registry 2004 ·Transplantation ·Meredith J. Aull, Joseph F. Buell, Jennifer Trofe, M. Roy First, Rita R. Alloway, Michael J. Hanaway, Lynne E. Wagoner, Thomas G. Gross, T M. Beebe, E. Steve Woodle	36
11	842-6 Anemia is associated with reduced health status measures in patients with heart failure: Results from the STAMINA: HFP (study of anemia in a heart failure population) registry 2004 ·Journal of the American College of Cardiology ·Kirkwood F. Adams, Ileana L. Piña, (unknown), Lynne E. Wagoner, Stephanie H. Dunlap, Todd A. Schwartz, Wendy A. Gattis, Mandeep R. Mehra, Jalal K. Ghali, D. Wolinski, William A. Pitt, John Kim, Javed Butler, Ron M. Oren	4
12	Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy 2003 ·Journal of Cardiac Failure ·Myron C. Gerson, Nancy McGuire, Lynne E. Wagoner	32
13	Infections in the heart transplant recipient 2003 ·Critical Care Nursing Clinics of North America ·Linda S. Baas, Barbara Bell, (unknown), Nancy McGuire, Lynne E. Wagoner	1
14	Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure 2002 ·American Heart Journal ·Lynne E. Wagoner, L. Craft, (unknown), Nancy McGuire, (unknown), Gerald W. Dorn, Stephen B. Liggett	101
15	Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine 2002 ·Journal of Nuclear Cardiology ·Myron C. Gerson, L. Craft, Nancy McGuire, Damodhar P. Suresh, William T. Abraham, Lynne E. Wagoner	65
16	The Challenge of Managing the Care of Older Heart Transplant Recipients 2002 ·AACN Clinical Issues Advanced Practice in Acute & Critical Care ·Linda S. Baas, Barbara Bell, (unknown), (unknown), Lynne E. Wagoner	3
17	Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure breakdown → 2000 ·New England Journal of Medicine ·Wilson S. Colucci, Uri Elkayam, Darlene P. Horton, William T. Abraham, Robert C. Bourge, Allen D. Johnson, Lynne E. Wagoner, Michael M. Givertz, Chang‐seng Liang, (unknown), W. Herbert Haught, Thierry H. LeJemtel	669
18	Prediction of human transplantation arteriopathy and coronary events with lung/heart count ratios during intravenous dipyridamole thallium-201 imaging 1999 ·American Heart Journal ·Daniel J. Lenihan, (unknown), (unknown), Chih‐Yu Tseng, Geetha Bhat, Lynne E. Wagoner, Richard A. Walsh, Myron C. Gerson	8
19	The cellular pathophysiology of progression to heart failure 1996 ·Current Opinion in Cardiology ·Lynne E. Wagoner, Richard A. Walsh	33
20	A PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOPHOSPHAMIDE AND AZATHIOPRINE FOR EARLY REJECTION PROPHYLAXIS AFTER CARDIAC TRANPLANTATION DECREASED SENSITIZATION TO OKT3 1994 ·Transplantation ·(unknown), Michael R. Bristow, John B. OʼConnell, R D Ensley, Stephanie L. Olsen, Elizabeth H. Hammond, Lynne E. Wagoner, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact